ClinicalTrials.gov
ClinicalTrials.gov Menu

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00825045
Recruitment Status : Recruiting
First Posted : January 19, 2009
Last Update Posted : November 30, 2017
Sponsor:
Information provided by (Responsible Party):
Ariel Graff, Centre for Addiction and Mental Health

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018